EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma

Mark Gurnell iD, Amr Radwan iD, Claus Bachert, Njira Lugogo, Seong H Cho iD, Scott Nash iD, Haixin Zhang, Asif H Khan iD, Juby A Jacob-Nara iD, Paul J Rowe, Yamo Deniz

Journal of Asthma and Allergy · 2024-01 · Volume 17 · 1-8

DOI: 10.2147/jaa.s420140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asthma and Allergy, 2024-01. Verfasst von Mark Gurnell und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

LIBERTY SINUS-24LIBERTY SINUS-52asthma controlasthma exacerbationchronic rhinosinusitis with nasal polypssystemic corticosteroids

Autor:innen und Institutionen

  • Department of Medicine, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK.
  • Global Medical Affairs, Regeneron Pharmaceuticals Inc., Uxbridge, UK.
  • Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Münster, Münster, Germany.
  • International Airway Research Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Division of ENT Diseases, CLINTEC, Karolinska Hospital, Stockholm University, Stockholm, Sweden.

ORCID-Profile: Mark Gurnell, Amr Radwan, Seong H Cho, Scott Nash, Asif H Khan, Juby A Jacob-Nara

Zitieren

APA

Gurnell, M., Radwan, A., Bachert, C., Lugogo, N., Cho, S. H., Nash, S., Zhang, H., Khan, A. H., Jacob-Nara, J. A., Rowe, P. J., & Deniz, Y. (2024). Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma. Journal of Asthma and Allergy, Volume 17, 1-8. https://doi.org/10.2147/jaa.s420140

Vancouver

Gurnell M, Radwan A, Bachert C, Lugogo N, Cho SH, Nash S, et al. Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma. Journal of Asthma and Allergy. 2024;Volume 17:1-8. doi:10.2147/jaa.s420140

BibTeX
@article{Gurnell2024,
  author = {Gurnell, Mark and Radwan, Amr and Bachert, Claus and Lugogo, Njira and Cho, Seong H and Nash, Scott and Zhang, Haixin and Khan, Asif H and Jacob-Nara, Juby A and Rowe, Paul J and Deniz, Yamo},
  title = {Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma},
  journal = {Journal of Asthma and Allergy},
  year = {2024},
  volume = {Volume 17},
  pages = {1--8},
  doi = {10.2147/jaa.s420140}
}
Kostenlos starten →